Phreesia

AI Integration And Digital Adoption Will Expand Healthcare Services

AnalystConsensusTarget

Not Invested

Consensus Narrative from 14 Analysts

Published

27 May 25

Updated

08 Aug 25

AnalystConsensusTarget's Fair Value

US$32.21

16.2% undervalued

08 Aug

US$27.01

19.8%

-1.0%

Author's Valuation

US$32.2

16.2% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

US$32.2

16.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

10.47%

Healthtech revenue growth rate

4.69%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.82%

Calculation

US$51.05m

Earnings '28

51.38x

PE Ratio '28

US$2.62b

Market Cap '28

US$2.62b

Market Cap '28

65.01m

No. shares '28

US$40.34

Share Price '28

US$40.34 Share Price '28

Discounted to 2025 @ 7.80% p.a.

US$32.21

Fair Value '25